Back to Journals
Drug, Healthcare and Patient Safety
Department of Pharmaceutical Health Outcomes and Policy, University of Houston, United States
Editor-in-Chief: Professor Rajender Aparasu
Dr. Aparasu is Professor and Chair at University Of Houston - College Of Pharmacy. He is a nationally renowned scholar and educational leader with over 20 years of experience in the areas of pharmaceutical outcomes research and policy. He started his academic career at South Dakota State University – College of Pharmacy in 1995 after obtaining his PhD from the University of Louisiana – Monroe. He joined the University of Houston - College of Pharmacy in 2006. He has trained over have 20 graduate students and post-doctoral fellows. The goal of his research team is to provide real word evidence for practice and policy using available data sources based on novel methodological and analytical approaches for causal inference in observational research. His research focused on quality of pharmacotherapy issues in the elderly. His current federally funded research is evaluating safety profiles of anticholinergic medications in the elderly nursing home residents.
Dr. Aparasu served on various national patient safety and medication therapy management task forces, and received numerous Federal and non-Federal grants to address geriatric quality of pharmaceutical care. He has edited two books, Research Methods for Pharmaceutical Practice and Policy and Principles of Research Design and Drug Literature Evaluation. He is a peer reviewer for numerous pharmacy and medical journals with over 100 peer-reviewed publications. He serves on numerous editorial boards of pharmacy and medical journals. He has been recognized as an Exceptional Peer Reviewer by prestigious journals. He also serves as a grant reviewer for the American Heart Association (AHA), Patient-Centered Outcomes Research Institute (PCORI), and National Institutes of Health (NIH). He was recognized by his peers with 2012 Fellow of the American Pharmacists Association (FAPhA) for his exemplary professional achievements and outstanding service and contribution to the pharmacy profession.
School of Pharmacy, Faculty of Health and Medical Sciences, Taylor's University, Malaysia
Associate Editor: Siew Siang Chua
Professor Chua Siew Siang is a Professor at Taylor’s University in Malaysia. She is the Head of the School of Pharmacy in Taylor’s University. Prof. Chua obtained her Bachelor of Pharmacy (Hons) from Universiti Sains Malaysia (USM). She served as a hospital pharmacist in Malaysia for about 4 years. She then obtained the Postgraduate Research Scholarship from the University of Queensland to pursue her PhD degree in Pharmacy Practice. Prof. Chua started her academic career with the pharmacy twinning programme between the Institute of Technology MARA (ITM) and the Northern Consortium of the United Kingdom (NCUK) in 1991. In 1995, she was transferred to the University of Malaya, as one of the pioneer lecturers of the pharmacy programme in this university where she served for 22 years. In 2017, Prof. Chua joined the School of Pharmacy in Taylor’s University, Malaysia.
Prof. Chua’s main research areas are related to community and hospital pharmacy practice which include medication safety and pharmaceutical care. She has published numerous research papers in refereed journals and presented in many national and international conferences as well as involved in organizing many conferences. She has also served as a peer reviewer for national and international journals since the year 2000. In addition, Prof. Chua is a very active member of the Malaysian Pharmaceutical Society (MPS) and has served as a council member for two terms. Currently, she is the Assistant Principal of the Malaysian Academy of Pharmacy. She has also served in various committees under the Ministry of Health Malaysia. These included the Pharmacy Board of Malaysia and the Drug Control Authority. She was involved in the development and formulation of the Community Pharmacy Benchmarking Guideline, Criteria for Continuous Professional Development and Guidelines on Approval and Recognition of a Pharmacy Programme in Malaysia. She has been one of the assessors for pharmacy programmes in Malaysia since 1998.
Department of Epidemiology, Johns Hopkins University, United States
Associate Editor: Hemalkumar B Mehta
Dr. Mehta is an Assistant Professor in the Department of Surgery and Department of Internal Medicine at the University of Texas Medical Branch, Galveston. Dr. Mehta received Master of Science in Pharmacy Administration (2010) and PhD in Pharmaceutical Health Outcomes and Policy (2014) from the University of Houston. He is clinically trained in Pharmacy from the North Maharashtra University (2006) in India. Dr. Mehta started his academic career at the University of Texas Medical Branch in 2014 after completing his PhD.
Dr. Mehta's research interest includes pharmacoepidemiology, methodological research and surgical outcomes research. He has expertise in evaluating health, economic and patient reported outcome using large administrative claims, electronic medical records and survey data. He has published over 40 peer-reviewed manuscripts and presented over 60 research abstracts at national and international conferences. Dr. Mehta is a peer reviewer for several pharmacy and surgery journals. He has been recognized for his exceptionally fine quality of reviews by the Value in Health and the Annals of Internal Medicine.
Dr. Aagaard, Havemann Law Firm Ltd. Copenhagen, Denmark.
Dr Ahmed, MRSPH, Senior Lecturer in Clinical Pharmacy at University of Lincoln, United Kingdom.
Chul Ahn, Professor and Director of Biostatistics and Research Design, Department of Population and Data Sciences, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Dr. Bontha V. Babu, Head Scientist, Division of Socio-Behavioural & Health Systems Research, Indian Council of Medical Research, New Delhi, India.
Charles L Bennett, Frank P and Josie M Fletcher Chair and Smart State Center Director, South Carolina College of Pharmacy and the Hollings Cancer Center, University of South Carolina and the Medical University of South Carolina, Columbia, SC, USA
Jongwha Chang, MSPH, PhD, Assistant Professor of Pharmacy Administration, University of Texas, School of Pharmacy, El Paso, TX, USA.
Prof. Giorgio L. Colombo, Adjunct Professor of Organization Theory, University of Pavia, Department of Drug Sciences, Italy
Robin J. Jacobs, PhD, MSW, MS, MPH, Director of Graduate Medical Education, Statistical Consultant, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Florida, United States.
Gerald L. Klein, MD, Clinical Research, Medsurgpi LLC, United States.
Peter Koulen, PhD, FARVO, Professor of Ophthalmology and Biomedical Sciences, University of Missouri, Kansas City, United States.
Peter R. Martin, M.D., Professor of Psychiatry and Behavioral Sciences, Professor of Pharmacology, Vanderbilt Psychiatric Hospital, Vanderbilt University School of Medicine, Nashville, TN, USA
Jagathesh Chandra Bose Rajendran, Biomedical and translational medicine, Masonic Medical Research Institute, Utica, NY, USA.
Raffaele Serra, MD, PhD, Director of CIFL - "Interuniversity Center of Phlebolymphology -International Research and Educational Program in Clinical and Experimental Biotechnology”. Headquarters at University Magna Graecia of Catanzaro, Associate Professor of Vascular Surgery, University Magna Graecia of Catanzaro, Italy.
Prof. Bach Tran is Vice Head of Department of Health Economics, Hanoi Medical University, Vietnam.
Prof. Dr. Trkulja
Dr Vladimir Trkulja, Department of Pharmacology, Zagreb University School of Medicine, Croatia.
Chiara Verbano, Ph.D., Professor of Management and Engineering Economics and Innovation and Project Management at the Department of Management Engineering of the University of Padova, Italy.
Karen Dineen Wagner, M.D., Ph.D., Professor and Chair, Department of Psychiatry & Behavioral Sciences, The University of Texas Medical Branch, Galveston, Texas, USA
John A. Zaia, M.D., Director, Center for Gene Therapy, Aaron D. and Edith Miller Chair for Gene Therapy; Hematologic Malignancies and Stem Cell Transplantation Institute Department of Hematology, City of Hope, Duarte, CA, USA